Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
OGEDA SA	RUE ADRIENNE BOLLAND 47 CHARLEROI 6041

International Classification(s)

• C07D:HETEROCYCLIC COMPOUNDS

• [Classification Symbol]

• [Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Batt, Frederic	Lyon, FR	4	21
Bousmaqui, Mohamed E	Aul-Noy-lez-Valenciennes, FR	1	2
Dutheuil, Guillaume	Vedrin, BE	30	141
Fraser, Graeme L	Bousval, BE	21	396
Hoveyda, Hamid R	Brussels, BE	42	506
Roy, Marie-Odile	Paris, FR	11	80

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
7.5 Year Payment	$3600.00	$1800.00	$900.00	Mar 4, 2026
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Mar 4, 2030

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 7.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
September 04, 2018	US,10065961,B2   US10065961B2	GRANTED PATENT AS SECOND PUBLICATION
February 02, 2017	US,20170029429,A1   US20170029429A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent Application No: 10065961

Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof

---

 

Legal Events